| The Global X Cannabis ETF (POTX) seeks to invest in companies across the cannabis industry. This includes companies involved in the legal production, growth and distribution of cannabis and industrial hemp, as well as those involved in providing financial services to the cannabis industry, pharmaceutical applications of cannabis, CBD, or other related uses. |
FUND BASICS
| Category |
Global Equities |
| Fund Sponsor |
Global X |
| Website |
www.globalxfunds.com |
| Inception date |
Sep 18, 2019 |
| Assets (mns) |
$0 |
| Currency |
USD |
| Expense ratio |
51 bp |
| Distributions |
Quarterly |
FUND STRUCTURE
| Regulation |
Open-Ended Fund |
| Custodian |
|
| Weighting |
Market Cap |
| Index replication |
|
| Uses derivatives |
No |
| Options available |
Yes |
CONSTITUENT BREAKDOWN
| No. of constituents |
0 |
| Wgt avg mkt cap (mns) |
$0 |
| Large cap (>$10bn) |
0.0% |
| Mid cap ($2-10bn) |
0.0% |
| Small cap (<$2bn) |
0.0% |
| Developed mkts |
0.0% |
| Emerging mkts |
0.0% |
TOP TEN HOLDINGS
|
0.0 % |
Total |
0.0 % |
TOP COUNTRY EXPOSURE
 |
|
0.0 % |
Standardized Annual Returns (thru January 31)
| Year-to-date |
1 year |
5 years |
10 years |
Since Incep. |
| -10.6% |
-54.0% |
-- |
-- |
-48.6% |
Market Correlations
| versus... |
Beta |
R-squared |
| S&P500 |
1.42 |
37% |
| MSCI EAFE |
1.29 |
28% |
| MSCI Emg. Mkts. |
0.89 |
14% |
Technical Indicators
| Recent close |
$0.00 |
| 30d moving avg. |
$5.61 |
| Annualized volatility |
41.1% |
| Short interest (ETF) |
0.6% |
| Relative strength (RSI) |
52 |
Liquidity measures
| Avg. volume (thou.) |
76 |
| Turnover |
1.5% |
| Bid/Ask (% of price) |
1.51% |
| ADV underlying (mns) |
$0 |
 |
There were no matches found with other funds under coverage. |
Content on this tab for subscribers only**
| |
2019 |
2020 |
2021 |
2022 |
2023 |
2024E |
2025E |
| Sales per share |
** |
** |
** |
** |
** |
** |
** |
| Earnings per share |
** |
** |
** |
** |
** |
** |
** |
Dividends per share  |
** |
** |
** |
** |
** |
** |
** |
| Book value per share |
** |
** |
** |
** |
** |
** |
** |
| Sales per share growth |
|
**% |
**% |
**% |
**% |
**% |
**% |
| EPS growth |
|
**% |
**% |
**% |
**% |
**% |
**% |
| Sales per share growth |
|
**% |
**% |
**% |
**% |
**% |
**% |
| EPS growth |
|
**% |
**% |
**% |
**% |
**% |
**% |
| Long term EPS growth est. |
**% |
|
Debt-to-equity |
**x |
| Asset turnover |
**% |
|
Assets-to-equity |
**x |
Revision activity*
|
| *Six months ago = 100 |
Compound annual growth rates
|
Content on this tab for subscribers only
| |
2023 |
2024E |
2025E |
| Price-to-sales |
** |
** |
** |
| Price-to-earnings |
** |
** |
** |
| Price-to-cash flow |
** |
** |
** |
| Price-to-growth |
** |
** |
** |
| Price-to-book value |
** |
** |
** |
| Yield |
** |
** |
** |
AVOID |
| Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may not be relevant. |
| Calculation of ALTAR Score™ |
| Avg. Return on Equity |
0.0 |
% |
| Divided by: Fwd. P/BV |
0.0 |
x |
| Less: Expense ratio |
51 |
bp |
| Equals: ALTAR Score |
0.0 |
% |
|
| More information on ALTAR Score™ |
|
|
|
Fundamentals